Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$515.17 USD
+7.75 (1.53%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $515.17 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$515.17 USD
+7.75 (1.53%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $515.17 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Zacks News
Amedisys (AMED) Suffers From Low Occupancy Amid Pandemic
by Zacks Equity Research
The prolonged and lingering impact of COVID-19 on Amedisys (AMED) Hospice business has hampered its ability to grow at the earlier-projected rates.
Thermo Fisher (TMO) Hits a 52-Week High: What's Driving It?
by Zacks Equity Research
Strong performance by the four reported business segments is driving the top line for Thermo Fisher (TMO).
Is Intuitive Surgical (ISRG) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (ISRG) Outperforming Other Medical Stocks This Year?
3 Medical Instruments Stocks Countering Industry Headwinds
by Urmimala Biswas
The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most. However, falling demand for COVID-19 tests might disrupt the trend.
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
The Zacks Analyst Blog Highlights: Nike, General Motors, Marsh & McLennan, Capital One Financial and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, General Motors, Marsh & McLennan, Capital One Financial and Intuitive Surgical
Here's How Much a $1000 Investment in Intuitive Surgical, Inc. Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
The Zacks Analyst Blog Highlights: Microsoft, Morgan Stanley, Honeywell International, Intuitive Surgical and ConocoPhillips
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Morgan Stanley, Honeywell International, Intuitive Surgical and ConocoPhillips
U.S. Economy Exceeds Pre-Pandemic Level: 5 Top Picks
by Nalak Das
We have narrowed down our search to five corporate giants that have seen positive earnings estimate revisions for 2021 within the last 7 days. These are: GM, NKE, MMC, ISRG and COF.
Earnings Season Scorecard and Research Reports for Microsoft, Morgan Stanley & Honeywell
by Sheraz Mian
Today's Research Daily features update on the Q2 earnings season and new research reports on Microsoft (MSFT), Morgan Stanley (MS), Honeywell (HON) & others.
Top Ranked Momentum Stocks to Buy for July 28th
by Zacks Equity Research
CROX, ISRG, MIDD, and DHR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2021
Why Intuitive Surgical, Inc. (ISRG) Might be Well Poised for a Surge
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why You Should Invest In Globus Medical (GMED) Now
by Zacks Equity Research
Strong first-quarter performance by the U.S. Spine and Enabling Technologies business contributed to Globus Medical's (GMED) top line.
Is Intuitive Surgical (ISRG) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (ISRG) Outperforming Other Medical Stocks This Year?
Intuitive Surgical (ISRG) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter results reflect strong segmental performance.
Intuitive Surgical, Inc. (ISRG) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 24.05% and 13.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
This Week's Must-See Earnings Charts
by Tracey Ryniec
All eyes will be on these five companies. Can they beat again?
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.37%: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $950.11, marking a -0.37% move from the previous day.
What's in Store for Intuitive Surgical's (ISRG) Q2 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance at Instruments & Accessories segment.
Intuitive Surgical, Inc. (ISRG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.
Intuitive Surgical (ISRG) Hits 52-Week High: What's Behind It?
by Zacks Equity Research
Investors are optimistic about Intuitive Surgical's (ISRG) strength in its da Vinci surgical system.
Penumbra (PEN) Gets FDA Nod for RED 62, Grows Thrombectomy Line
by Zacks Equity Research
Penumbra (PEN) to initiate commercialization of RED 62 Reperfusion Catheter post FDA clearance.
Thermo Fisher (TMO) Invites Applications for Oncomine Program
by Zacks Equity Research
Thermo Fisher (TMO) to review research proposals eligible for the Oncomine Clinical Research Grant program.
Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ISRG) Outperforming Other Medical Stocks This Year?